Declan Doogan Purchases 53,000 Shares of Tenax Therapeutics (NASDAQ:TENX) Stock
MarketBeat
Tenax Therapeutics, Inc. (NASDAQ:TENX - Get Free Report) Director Declan Doogan bought 53,000 shares of Tenax Therapeutics stock in a transaction dated Wednesday, September 16th. The stock was purchased at an average cost of $1.92 per share, for a total transaction of $101,760.00. Following the completion of the acquisition, the director directly owned 55,274 shares of the company's stock, valued at approximately $106,126.08. The trade was a 2,330.69% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
NASDAQ:TENX
